Astra gets Crestor boost ahead of key patent trial – Reuters
by Admin on 09/02/10 at 5:52 am
">TopNews United States Astra gets Crestor boost ahead of key patent trial Reuters LONDON, Feb 9 (Reuters) – AstraZeneca (AZN.L) has pulled ahead of the pack with an expanded label in the United States for its heart drug Crestor, but the medicine's future remains uncertain ahead of a vital patent trial this month.

Read more here:
Astra gets Crestor boost ahead of key patent trial – Reuters